Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  29 (2025)
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 28 , ISSUE 8 ( August, 2024 ) > List of Articles

Original Article

Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure

Doaa M Magdy

Keywords : Acute hypoxemic respiratory failure, High-flow nasal oxygen, Pneumonia

Citation Information : Magdy DM. Outcome of Early Initiation of High-flow Nasal Oxygen Therapy among Pneumonia Patients Presenting with Acute Hypoxemic Respiratory Failure. Indian J Crit Care Med 2024; 28 (8):753-759.

DOI: 10.5005/jp-journals-10071-24769

License: CC BY-NC 4.0

Published Online: 31-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: High-flow nasal oxygen (HFNO) therapy is an upcoming and beneficial modality for patients with acute hypoxemic respiratory failure (AHRF). Objectives: To evaluate whether early use of HFNO in pneumonia patients with AHRF can reduce the need for invasive ventilation. Patients and methods: In this prospective, randomized controlled trial, 160 patients who fulfilled the criteria were included. The patient's characteristics, sequential organ failure assessment score, and simplified acute physiology score were recorded. Respiratory rate (RR), and oxygenation parameters (PaO2/FiO2), and RR-oxygenation index at selected time intervals were collected and analyzed. The primary outcome was the number of patients who needed intubation. Secondary outcomes included length of intensive care unit (ICU) and hospital stay and mortality at day 28. Results: The rate of intubation was not statistically significant between the two groups 15 vs 18.7%; difference 3.7% [(95% confidence interval (CI): 2.5–5.7%]. In 48-hour time periods, the mean PaO2/FiO2 ratio was significantly increased in the HFNO group compared with the non-invasive ventilation (NIV) group. The RRs and heart rate (HR) showed a significant decrease in the HFNO group. The length of ICU and hospital stays was not different between both groups. No significant differences were found in mortality rates between the HFNO and NIV groups 9 (11.2%) and 10 (12.5%), with 1.3% (95% CI: 0.7–3.8%) (p = 0.21). Multivariate analysis demonstrated that low baseline PaO2/FiO2, Respiratory rate-oxygenation index (ROX index) ≤ 5.4 measured at 12 hour and high severity scores were independent risk factors for intubation. Conclusion: Treatment with HFNO did not reduce the need for intubation among patients with pneumonia-induced AHRF, despite the improved PaO2/FiO2 observed with HFNO compared with NIV.

HTML PDF Share
  1. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196. DOI: 10.1056/NEJMoa1503326.
  2. Renda T, Corrado A, Iskandar G, Pelaia G, Abdalla K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anaesthesia. Br J Anaesth 2018;120(1):18–27. DOI: 10.1016/j.bja.2017.11.010.
  3. Ni YN, Luo J, Yu H, Liu D, Ni Z, Cheng J, et al. Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? A systematic review and meta-analysis. Chest 2017;151(4):764–775. DOI: 10.1016/j.chest.2017.01.004.
  4. Zhou X, Yao S, Dong P, Chen B, Xu Z, Wang H. Preventive use of respiratory support after scheduled extubation in critically ill medical patients-a network meta-analysis of randomized controlled trials. Crit Care 2020;(1):370. DOI: 10.1186/s13054-020-03090-3.
  5. Levy SD, Alladina JW, Hibbert KA, Harris RS, Bajwa EK, Hess DR. High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet 2016;(387):1867–1878. DOI: 10.1016/S0140-6736(16)30245-8.
  6. Goh KJ, Chai HZ, Ong TH, Sewa DW, Phua GC, Tan QL. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate. J Intensive Care 2020;(8):41. DOI: 10.1186/s40560-020-00458-z.
  7. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368–1376. DOI: 10.1164/rccm.201803-0589OC.
  8. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):61–111. DOI: 10.1093/cid/ciw353.
  9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl. 2): S27–S72. DOI: 10.1086/511159.
  10. Zhan Q, Sun B, Liang L, Yan X, Zhang L, Yang J, et al. Early use of noninvasive positive pressure ventilation for acute lung injury: A multicenter randomized controlled trial. Crit Care Med 2012;40(2):455–460. DOI: 10.1097/CCM.0b013e318232d75e.
  11. Ferreira F, Bota D, Bross A, Mélot C, Vincent J. Serial evaluation of the SOFA scores to predict outcome in critically ill patients. JAMA 2001;286(14):1754–1758. DOI: 10.1001/jama.286.14.1754.
  12. Le Gall J, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270(24):2957–2963. DOI: 10.1001/jama.270.24.2957.
  13. American Thoracic Society ATS statement: Guideline for the 6 minute walk test. Am J Resp Crit Care Med 2002;166(1):111–117. DOI: 10.1164/ajrccm.166.1.at1102.
  14. Brown CA, Bair AE, Pallin DJ, Walls RM, Investigators NI. Techniques, success, and adverse events of emergency department adult intubations. Ann Emerg Med 2015;65(4):363–370. DOI: 10.1016/j.annemergmed.2014.10.036.
  15. Rochwerg B, Granton D, Wang D, Helviz Y, Einav S, Frat J, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: A systematic review and meta-analysis. Intensive Care Med 2019;45(5):563–572. DOI: 10.1007/s00134-019-05590-5.
  16. Park S, Jeon K, Oh DK, Choi EY, Seong GM, Heo J, et al. Normothermia in patients with sepsis who present to emergency departments is associated with low compliance with sepsis bundles and increased in-hospital mortality rate. Crit Care Med 2020;48(10):1462–1470. DOI: 10.1097/CCM.0000000000004493.
  17. Agarwal R, Aggarwal AN, Gupta D. Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome: A proportion meta-analysis. Respir Care 2010;55(12):1653–1660. PMID: 21122173.
  18. Chawla R, Mansuriya J, Modi N, Pandey A, Juneja D, Chawla A, et al. Acute respiratory distress syndrome: Predictors of noninvasive ventilation failure and intensive care unit mortality in clinical practice. J Crit Care 2016;31(1):26–30. DOI: 10.1016/j.jcrc.2015.10.018.
  19. Ou X, Hua Y, Liu J, Gong C, Zhao W. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: A meta-analysis of randomized controlled trials. CMAJ 2017;189(7): 260–267. DOI: 10.1503/cmaj.160570.
  20. Monro-Somerville T, Sim M, Ruddy J, et al. The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure. Crit Care Med 2017;45(4):449–456. DOI: 10.1097/CCM.0000000000002091.
  21. Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: A randomized clinical trial. Am J Respir Crit Care Med 2003;168(12): 1438–1444. DOI: 10.1164/rccm.200301-072OC.
  22. Rochwerg B, Einav S, Chaudhuri D, Mancebo J, Mauri T, Helviz Y, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: A clinical practice guideline. Intensive Care Med 2020;46(12):2226–2237. DOI: 10.1007/s00134-020-06312-y.
  23. Goligher EC, Slutsky AS. Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9):1128–1131. DOI: 10.1164/rccm.201701-0006ED.
  24. Mauri T, Turrini C, Eronia N, Grasselli G, Volta CA, Bellani G, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9): 1207–1215. DOI: 10.1164/rccm.201605-0916OC.
  25. Tonelli R, Fantini R, Tabbì L, Castaniere I, Pisani L, Pellegrino MR, et al. Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure. A pilot study. Am J Respir Crit Care Med 2020;202(4): 558–567. DOI: 10.1164/rccm.201912-2512OC.
  26. Grieco DL, Menga LS, Raggi V, Bongiovanni F, Anzellotti GM, Tanzarella ES, et al. Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2020;201(3):303–312. DOI: 10.1164/rccm.201904-0841OC.
  27. Carteaux G, Millán-Guilarte T, De Prost N, Rezazi K, Abid S, Thille AW, et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: Role of tidal volume. Crit Care Med 2016;44(2): 282–290. DOI: 10.1097/CCM.0000000000001379.
  28. Frat J, Ragot S, Coudroy R, Constantin JM, Girault C, Prat G, et al. Predictors of intubation in patients with acute hypoxemic respiratory failure treated with a noninvasive oxygenation strategy. Crit Care Med 2018;46(2):208–215. DOI: 10.1097/CCM.00000000000 02818.
  29. Parke RL, McGuinness SP, Eccleston ML. A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respir Care 2011;56(3):265–270. DOI: 10.4187/respcare.00801.
  30. Sayan İ, Altınay M, Çınar AS, Türk HŞ, Peker N, Şahin K, et al. Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia. Heart Lung 2021;50(3):425–429. DOI: 10.1016/j.hrtlng.2021.02. 009.
  31. Franco C, Facciolongo N, Tonelli R, Dongilli R, Vianello A, Pisani L, et al. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J 2020;56(5):2002130. DOI: 10.1183/13993003.02130-2020.
  32. Raoof S, Nava S, Carpati C, Hill NS. High-flow noninvasive ventilation and awake (nonintubation) proning in patients with coronavirus disease 2019 with respiratory failure. Chest 2020;158(5):1992–2002. DOI: 10.1016/j.chest.2020.07.013.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.